Company intelligence / Profile preview

Elesta

Florence, Tuscany, Italyelesta-gmbh.com ↗

Ownership: Private
Development stage: Other

Overview

Elesta’s EchoLaser technology enables micro-invasive laser ablation procedures guided by real-time ultrasound. Clinical data show that transperineal laser ablation with EchoLaser is feasible and safe in office settings for BPH, with sustained improvement in over 80% of patients at 3–6 months follow-up while preserving erectile function and ejaculation. The technology is supported by multiple studies across Europe, China, and now the USA.

Therapeutic areas: Men's HealthEndocrinologyOncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

National Ultrasound Inc. — exclusive US distributor partnership since 2020URN/Urology Research Network — clinical research partner in MiamiOther distribution partners globally

Beyond the preview

Go deeper on Elesta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elesta.

Explore the full profile